Viewing Study NCT06232902


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2025-12-26 @ 2:42 AM
Study NCT ID: NCT06232902
Status: COMPLETED
Last Update Posted: 2024-12-18
First Post: 2024-01-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Compare the Pharmacokinetics and Safety of QL1101 and EU-AvastinĀ® in Healthy Volunteers
Sponsor: Qilu Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module